The cholesterol content of biliary lipids increased significantly when 16 healthy volunteers ingested deoxycholic acid (DC) for two weeks in a daily dose of 100-150 mg. Serum cholesterol also fell significantly to 88% of the baseline levels. Since DC is formed in the colon we suggest that populations in whom there is a high colonic absorption of bacterially metabolized cholate-that is, DC-have an increased predisposition to cholesterol gall stones.
Introduction
In the U.K. gall stones usually contain over 50% cholesterol. ' Cholesterol is normally kept in solution in bile by the detergent action of bile salts and lecithin, and cholesterol gall stones can be formed only when there is a relative excess of cholesterol over detergent. 2 Once formed, cholesterol gall stones can be dissolved by the administration of chenodeoxycholate (CDC),3 a bile salt normally present and synthesized in the liver from cholesterol. The action of CDC is now thought to be due mainly to its effect on cholesterol metabolism,4 so that CDC administration reduces the secretion of cholesterol but not that of bile salts. ' In this respect CDC conjugates differ from those of cholate and its bacterial metabolite deoxycholate (DC), the other two main bile salts in bile. These do not appear to reduce cholesterol secretion when fed to laboratory animals,4 and cholic acid administration has been ineffective in dissolving human gall stones. 3 We have previously shown that an increase in the recirculation of DC reduces the amount of CDC in bile by selectively suppressing its synthesis.7 8 DC might therefore be an important determinant of cholesterol saturation in bile since it suppresses the one-bile salt known to decrease the secretion of cholesterol. The present study investigates the effect of increasing biliary DC on the saturation of cholesterol in bile.
Methods
Sixteen healthy medical students and hospital staff volunteered for these studies. Nine were men and seven were women. Their ages ranged from 21 to 54 years. The effect of DC administration on the composition of the bile salt pool in seven of them has already been reported.7 ' Fasting duodenal bile samples (3-5 ml) were obtained by intubation after an intravenous injection of pancreozymin (Boots). Each subject then took 100-150 mg DC (Weddel Pharmaceuticals) daily in divided doses for an average of two weeks. A further 3-5 ml of fasting duodenal bile was then obtained, and in nine subjects a third sample was aspirated two to three weeks after discontinuing DC.
Aliquots of fresh duodenal bile were assayed for total bile salts' and total phospholipid."°Biliary cholesterol was assayed," after Folch extraction."2 The results were expressed as a molar percentage of total biliary lipids-that is, moles cholesterol -moles (cholesterol + bile salts + phospholipid) x 100.
Fasting blood samples were obtained in 13 of the subjects at the same time as duodenal intubation was performed for estimation of serum cholesterol and triglyceride, bilirubin, alkaline phosphatase, and aspartate aminotransferase levels.
Results
The effect of feeding DC on the percentage (paired Student's t test: t = 2-57; P < 0-0125), rising from a mean of 8-6 ± 0 5% (S.E.) to 9 9 + 0.7%. No differences could be detected between the six subjects in whom the biliary cholesterol did not rise and the rest with regard to age, sex, bile salt composition, or serum lipid levels. The results remained significant (P < 0 005) when the bile lipid composition was expressed as a "lithogenic index" (calculated from Thomas and Hofmann's"3 equation based on the pooled data of Hegardt and Dam'4 and Holzbach et al."5 In the nine subjects whose bile composition was measured two to three weeks after discontinuing DC both the rise in biliary cholesterol associated with taking DC and the fall after discontinuing it were statistically significant (P < 0-05 and P < 0-025 respectively). In each of the six in whom it rose with therapy it subsequently fell. The mean values before starting and after stopping DC feeding differed by only 0O08%.
The effect of DC on the proportion of bile salts and phospholipid in bile showed no statistically significant trend (table I) .
Serum cholesterol levels, measured in 13 subjects, fell significantly while taking DC to an average of 88% of the original value (table II) . In the nine subjects whose levels were measured again after stopping DC both the fall and the subsequent rise in serum cholesterol levels were significant (t = 2-28, P < 0-05; and t -4-60, P < 0.01 respectively). The amount of change in serum cholesterol did not correlate significantly with that in biliary cholesterol. No consistent or significant change in serum triglyceride levels were noted. In this study the primary renal disease has been sought in all people aged 15-55 years, who entered the renal replacement programme or who died with advanced intrinsic renal failure at Sydney Hospital in a seven-year period. An aetiological rather than a pathological diagnosis was made whenever possible in those in whom the renal disorder was identified as pyelonephritis, papillary necrosis, interstitial nephritis, or toxic nephropathy.
Patients
The records, histological sections of the kidneys, and pyelographic films of all patients who had either presented for dialysis or transplantation or died with intrinsic renal failure (serum
